Research-backed, community-driven, and rooted in evidence-based outcomes. Our world is facing a mental health pandemic, with more than 1/8th of the global population suffering from a clinical indication. Based on cutting-edge scientific research, rigorous case studies from various organizations, and our own beneficial experiences, we believe microdosing is a beneficial tool: both to better the well and to offer relief to those on traditional psychotropic medications. The Microdosing Collective wants to create momentum around changes to state and federal policy to support the legalization of microdosing, starting with psilocybin. We believe every human, if they wish, should be able to access microdosing medicine in a trustworthy and safe manner, with vetted and lab-tested products. Through our organization we will seek to expand access to those who may benefit from its use, welcome those from cultures for whom microdosing has been both a sacrament and a medicine, and seek to positively impact each community we touch. Founded by: Alli Schaper, Paul Austin, Josh Kappel Advisors: Courtney Barnes, Dr. Evan Lewis, John Downs, Dr. Ivan Casselman